CSIMarket
 
Aquestive Therapeutics Inc   (AQST)
Other Ticker:  
 
 

Aquestive Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aquestive Therapeutics Inc 's inventory turnover ratio, the ratio that measures Aquestive Therapeutics Inc 's ability to manage its supply chain, sequentially decreased to 3.11 in the fourth quarter 2023, which does not come as a surprise, as the Aquestive Therapeutics Inc continue to experience headwinds, which also impact its supply chain. Aquestive Therapeutics Inc 's average inventory processing period in the Dec 31 2023 quarter, has increased to 117 days, from 78 days, in the Sep 30 2023 quarter.

Within Healthcare sector 83 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 394 in the third quarter 2023, to 634.

AQST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aquestive Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?


AQST Inventory Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Inventory Growth 17.11 % 5.26 % 18.81 % 50.81 % 43.14 %
Y / Y Cost of Sales Growth -66.77 % 3.74 % 26.23 % 12.41 % 58.82 %
Inventory Turnover Ratio (TTM) 3.11 4.69 4.73 4.68 5.09
AQST's Total Ranking # 634 # 394 # 434 # 421 # 773
Average inventory processing period 117 78 77 78 72
Seq. Inventory Growth -4.38 % 18.97 % -14.77 % 20.78 % -14.05 %
Seq. Cost of Sales Growth -2.48 % -27.49 % 39.69 % -66.36 % 204.45 %



Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 84
Overall Market # 634

Inventory Turnover Ratio Statistics
High Average Low
6.11 4.77 3.11
(Mar 31 2022)   (Dec 31 2023)




Financial Statements
Aquestive Therapeutics Inc 's Inventories $ 7 Millions Visit AQST's Balance sheet
Aquestive Therapeutics Inc 's Cost of Revenues TTM $ 21 Millions Visit AQST's Income Statement
What are AQST's Sales? Visit AQST's Sales by Segment

Other Inventory Turnover Ratios
Aquestive Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AQST's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AQST's Competitors
Inventory Turnover Ratio for AQST's Suppliers
Inventory Turnover Ratio for AQST's Customers

You may also want to know
AQST's Sales Growth Rates AQST's Pe Price to earnings ratio AQST's Receivables Turnover Ratio AQST's Stock Quote
AQST's Net Income Growth Rates AQST's Ps Price to Sales ratio AQST's Sales per Employee AQST's Asset Turnover Ratio
AQST's Net Margin AQST's Pb Price to Book ratio AQST's Financial Strength Ratios AQST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
National Vision Holdings Inc   8.26 $ 1,000.910  Millions$ 121  Millions
Novavax inc  8.14 $ 343.768  Millions$ 42  Millions
Charles River Laboratories International inc   7.52 $ 2,295.983  Millions$ 305  Millions
Castle Biosciences Inc   7.39 $ 44.982  Millions$ 6  Millions
Alimera Sciences Inc   7.34 $ 10.837  Millions$ 1  Millions
Hims and Hers Health Inc   7.25 $ 157.000  Millions$ 22  Millions
Owens and Minor inc  7.06 $ 8,208.000  Millions$ 1,163  Millions
Kewaunee Scientific Corporation  6.88 $ 150.625  Millions$ 22  Millions
Hutchmed china Limited  6.61 $ 331.984  Millions$ 50  Millions
Cardiff Lexington Corporation  6.59 $ 3.561  Millions$ 1  Millions
Fonar Corporation  6.39 $ 17.389  Millions$ 3  Millions
Veracyte inc   6.25 $ 88.913  Millions$ 14  Millions
Star Equity Holdings Inc   6.12 $ 33.859  Millions$ 6  Millions
Patterson Companies Inc   5.96 $ 5,166.391  Millions$ 867  Millions
Avantor Inc   5.30 $ 4,603.400  Millions$ 868  Millions
Lifemd Inc   5.28 $ 18.000  Millions$ 3  Millions
Incyte Corporation  5.18 $ 254.990  Millions$ 49  Millions
Enzo Biochem Inc  5.13 $ 49.539  Millions$ 10  Millions
Abbvie inc   5.11 $ 20,415.000  Millions$ 3,992  Millions
Integer Holdings Corporation  5.09 $ 1,178.000  Millions$ 232  Millions
Exact Sciences Corporation  5.08 $ 654.248  Millions$ 129  Millions
Cytosorbents Corporation  4.99 $ 13.000  Millions$ 3  Millions
Warby Parker Inc   4.86 $ 304.000  Millions$ 63  Millions
Cryoport inc   4.84 $ 133.923  Millions$ 28  Millions
Twist Bioscience Corporation  4.84 $ 168.474  Millions$ 35  Millions
Henry Schein Inc  4.58 $ 8,478.000  Millions$ 1,852  Millions
Catalyst Pharmaceuticals Inc   4.54 $ 51.967  Millions$ 11  Millions
Vericel Corporation  4.51 $ 61.940  Millions$ 14  Millions
Ufp Technologies Inc   4.42 $ 287.000  Millions$ 65  Millions
Precision Optics Corporation Inc   4.41 $ 13.019  Millions$ 3  Millions

Date modified: 2024-03-06T17:14:23+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com